Thursday, 20 March 2025 11:45 AM
Class Action
WASHINGTON, DC / ACCESS Newswire / March 20, 2025 / Investors in Maravai LifeSciences Holdings, Inc. ("Maravai" or the "Company") (NASDAQ:MRVI) are encouraged to take action if they purchased shares between August 7, 2024, and February 24, 2025 (the "Class Period") and suffered losses. A securities class action lawsuit has been filed against the Company, and the deadline to petition for lead plaintiff status is May 5, 2025.
Investors who wish to learn about their legal rights and potential compensation can click here or contact Cohen Milstein Sellers & Toll PLLC Partner Molly Bowen at[email protected].
WHAT INVESTORS NEED TO KNOW
A lawsuit filed in the U.S. District Court for the Southern District of California alleges that Maravai and certain senior executives violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by misleading investors about its financial reporting, revenue recognition, and goodwill valuation.
Specifically, the complaint claims that Maravai:
Lacked adequate financial controls, particularly in recognizing revenue.
Incorrectly reported revenue for key transactions in fiscal 2024.
Overstated its goodwill valuation, creating a false impression of financial stability.
Misrepresented its financial condition and growth potential, misleading shareholders.
On February 25, 2025, Maravai delayed its earnings release and annual report, citing revenue recognition concerns and a potential non-cash impairment charge. Following this disclosure, the Company's stock plunged 21.7%, leading to significant investor losses.
NEXT STEPS FOR INVESTORS
If you purchased MRVI shares during the Class Period and experienced financial losses, you may have the opportunity to serve as lead plaintiff in the lawsuit. The deadline to file for lead plaintiff status is May 5, 2025.
Important: Investors are not required to act as lead plaintiff to participate in potential compensation from the case.
WHY COHEN MILSTEIN?
With over 100 attorneys in eight offices, Cohen Milstein Sellers & Toll PLLC is a leading securities litigation firm that has recovered billions of dollars for investors. As co-lead counsel in In re Wells Fargo & Company Securities Litigation, Cohen Milstein helped secure a $1 billion recovery for shareholders in 2024. The firm's Securities Litigation practice is nationally recognized by The National Law Journal, Law360, Chambers USA, and The Legal 500. To learn more, visit www.cohenmilstein.com.
Prior results do not guarantee a similar outcome. This may be considered Attorney Advertising.
CONTACT INFORMATION:
Molly Bowen, Esq.
Licensed in DC, Florida, and Ohio
Cohen Milstein Sellers & Toll PLLC
1100 New York Avenue, N.W., Fifth Floor
Washington, D.C. 20005
Telephone: (888) 240-0775 or (202) 408-4600
Email: [email protected]
Website: www.cohenmilstein.com
# # #
SOURCE: Cohen Milstein Sellers & Toll PLLC